Menu

Another NFL Victim of Brain Trauma?

Former NFL linebacker Junior Seau commits suicide. Is head injury-induced dementia to blame?

May 3, 2012
Jef Akst

Junior SeauWIKIMEDIA COMMONS, JJ HALL

Former Pro Bowl linebacker Junior Seau died yesterday (May 2) from what police are calling a self-inflicted gunshot wound to the chest. The tragedy makes Seau, who played for the San Diego Chargers, Miami Dolphins, and New England Patriots during his career, the third former-NFL player to commit suicide in the last 15 months. Speculation is swirling that Seau's death, like the other two suicides, might all be linked to the head injuries the players enduring during their years on the football field.

Former Atlanta Falcon Ray Easterling and former Chicago Bear Dave Duerson also shot themselves recently, and both were suspected to have symptoms of dementia. Duerson even requested that his brain be used for research, and after his death, researchers at the Boston University School of Medicine examine his brain and found evidence of a neurodegenerative disease linked to concussions, called chronic traumatic encephalopathy (CTE). However, while Seau’s ex-wife Gina told The Associated Press that he sustained concussions during his career, it’s still unclear whether he suffered similar symptoms or if his suicide is related to the head trauma.

"We have no clues whatsoever," Gina Seau told ABC News. "We're as stunned and shocked as anyone else. We're horribly saddened. We miss him and we'll always love him."

If Seau was suffering, he wouldn’t be alone. “Thirty percent of our 116 players have major depression secondary to brain injuries,” Daniel Amen, founder of Amen Clinics, Inc., a company that's measuring blood flow and electrical activity in the brains of active and retired NFL players, told The Scientist. “These players do not know that is help is available to them…. With the right help there is great hope for them.”

Read more about CTE and its potential link to football-induced head trauma in “Punch Drunk,” The Scientist, December 2011.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.